Evidence map›Paper›PMID 32241839›Full record

ArticleHaematologica2021

Genotype-phenotype association and variant characterization in Diamond-Blackfan anemia caused by pathogenic variants in

Matthew D Gianferante, Marcin W Wlodarski, Evangelia Atsidaftos, Lydie Da Costa, Polyxeni Delaporta, Jason E Farrar, Frederick D Goldman, Maryam Hussain, Antonis Kattamis, Thierry Leblanc and 11 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Haematologica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00106015 (Diamond Blackfan Anemia Registry), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00106015 recruitingnot on this map

Diamond Blackfan Anemia Registry (DBAR)

TypeobservationalSponsorNorthwell HealthRan2004 to 2030Enrolled900ConditionsAnemia, Blood Disease
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Diamond-Blackfan anemia.Hematology. American Society of Hematology. Education Program · 2021
    Article
  14. Identification ofSaudi medical journal · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 6 countries.

Matthew D GianferanteDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Marcin W WlodarskiSt. Jude Children's Research Hospital, Memphis, TN, USA.
Evangelia AtsidaftosFeinstein Institute of Medical Research, Cohen Children's Medical Center, NY, USA.
Lydie Da CostaService Hematologie Biologique, Hopital Robert-Debré, Université de Paris, France.
Polyxeni DelaportaFirst Department of Pediatrics, National and Kapodistrian University of Athens, Greece.
Jason E FarrarArkansas Children Research Institute, University of Arkansas, Little Rock, USA.
Frederick D GoldmanUniversity of Alabama at Birmingham, Birmingham, AL, USA.
Maryam HussainFeinstein Institute of Medical Research, Cohen Children's Medical Center, NY, USA.
Antonis KattamisFirst Department of Pediatrics, National and Kapodistrian University of Athens, Greece.
Thierry LeblancService Hematologie Biologique, Hopital Robert-Debré, Université de Paris, France.
Jeffrey M LiptonFeinstein Institute of Medical Research, Cohen Children's Medical Center, NY, USA.
Charlotte M NiemeyerDivision of Pediatric Hematology and Oncology, University of Freiburg, Germany.
Dagmar PospisilovaPalacky University and University Hospital, Olomouc, Czech Republic.
Paola QuarelloRegina Margherita Children's Hospital, Torino, Italy.
Ugo RamenghiPediatric and Public Health Science, University of Torino, Torino, Italy.
Vijay G SankaranDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Adrianna VlachosFeinstein Institute of Medical Research, Cohen Children's Medical Center, NY, USA.
Jana VolejnikovaPalacky University and University Hospital, Olomouc, Czech Republic.
Blanche P AlterDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Sharon A SavageDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Neelam GiriDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Cohen Children's Medical Center · USDivision of Cancer Epidemiology and GeneticsNational and Kapodistrian University of Athens · GRNational Cancer Institute · USArkansas Children's Hospital · USBoston Children's Hospital · USHôpital Robert-Debré · FROspedale Regina Margherita · ITPalacký University Olomouc · CZSt. Jude Children's Research Hospital · USUniversité Paris Cité · FRUniversity Hospital Olomouc · CZUniversity of Alabama at Birmingham · USUniversity of Freiburg · DEUniversity of Turin · IT

Funding

Clinical Genetic Studies of Familial and Hereditary Cancer SyndromesZIACP010144 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$111.8M
The DBA Registry: A Vital Tool for the Study of DBAR01HL079571 · NHLBI · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI LIPTON, JEFFREY M · 2004 to 2018
$5.3M
NCI NIH HHS HHSN261201100018CNHLBI NIH HHS R01 HL079571
6 · The paper itself

Abstract

Diamond Blackfan anemia (DBA) is predominantly an autosomal dominant inherited red cell aplasia primarily caused by pathogenic germline variants in ribosomal protein genes. DBA due to pathogenic RPL35A variants has been associated with large 3q29 deletions and phenotypes not common in DBA. We conducted a multi-institutional genotype-phenotype study of 45 patients with DBA associated with pathogenic RPL35A germline variants and curated the variant data on 21 additional cases from the literature. Genotype-phenotype analyses were conducted comparing patients with large deletions versus all other pathogenic variants in RPL35A. Twenty-two of the 45 cases had large deletions in RPL35A. After adjusting for multiple tests, a statistically significant association was observed between patients with a large deletion and steroid-resistant anemia, neutropenia, craniofacial abnormalities, chronic gastrointestinal problems, and intellectual disabilities (p<0.01) compared with all other pathogenic variants. Non-large deletion pathogenic variants were spread across RPL35A with no apparent hot spot and 56% of the individual family variants were observed more than once. In this, the largest known study of DBA patients with pathogenic RPL35A variants, we determined that patients with large deletions have a more severe phenotype that is clinically different from those with non-large deletion variants. Genes of interest also deleted in the 3q29 region that could be associated with some of these phenotypic features include LMLN and IQCG. Management of DBA due to large RPL35A deletions may be challenging due to complex problems and require comprehensive assessments by multiple specialists including immunologic, gastrointestinal, and developmental evaluations to provide optimal multidisciplinary care.

Indexed as

Anemia, Diamond-BlackfanGenetic Association StudiesHumansMutationPhenotypeRibosomal ProteinsRibosomal ProteinsRPL35A protein, human

Identifiers

PMID32241839
PMCPMC8094096
OpenAlexW3014514248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.